about
Application of (68)Ga-PRGD2 PET/CT for αvβ3-integrin imaging of myocardial infarction and stroke.Periodicity in tumor vasculature targeting kinetics of ligand-functionalized nanoparticles studied by dynamic contrast enhanced magnetic resonance imaging and intravital microscopyIn vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization.A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer.Lymphatic imaging: focus on imaging probes.Radiolabeling and evaluation of (64)Cu-DOTA-F56 peptide targeting vascular endothelial growth factor receptor 1 in the molecular imaging of gastric cancer.Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121.PET imaging of CD105/endoglin expression with a ⁶¹/⁶⁴Cu-labeled Fab antibody fragmentInterrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles.Prospective of ⁶⁸Ga-radiopharmaceutical development.Enhanced fluorescence diffuse optical tomography with indocyanine green-encapsulating liposomes targeted to receptors for vascular endothelial growth factor in tumor vasculatureCurrent and future options for the diagnosis of malignant pleural effusion.Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer.Molecular imaging-its current role in cancer.Comparison of three dimeric 18F-AlF-NOTA-RGD tracers.Mechanistic target of rapamycin small interfering RNA and rapamycin synergistically inhibit tumour growth in a mouse xenograft model of human oesophageal carcinoma.Preclinical evaluation of [111 In]MICA-401, an activity-based probe for SPECT imaging of in vivo uPA activity.Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation.Stereotactic Comparison Study of (18)F-Alfatide and (18)F-FDG PET Imaging in an LLC Tumor-Bearing C57BL/6 Mouse Model.Molecular imaging and radiotherapy: theranostics for personalized patient managementMiR-205/YAP1 in Activated Fibroblasts of Breast Tumor Promotes VEGF-independent Angiogenesis through STAT3 Signaling.Binding of αvβ3 Integrin-Specific Radiotracers Is Modulated by Both Integrin Expression Level and Activation Status.Imaging angiogenesis using 68Ga-NOTA-PRGD2 positron emission tomography/computed tomography in patients with severe intracranial atherosclerotic disease.Quantum dot multiplexing for the profiling of cellular receptors.PET molecular imaging of angiogenesis with a multiple tyrosine kinase receptor-targeted agent in a rat model of myocardial infarction.Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer.A Systematic Comparative Evaluation of Ga-Labeled RGD Peptides Conjugated with Different Chelators
P2860
Q30832796-FDE2B8DB-2A02-44B8-BADF-3F7F2E74089BQ34050862-CF3E4FC4-80B8-47C6-8730-EC6D8416182EQ34081980-AAC3FFD4-F8AA-4ECF-9933-AED4C5394326Q35407573-E3E1E202-6126-42B7-85C0-99D4F1977149Q35475925-8F98F2D0-904F-4D16-8CCC-DE9DB620C8DCQ36420140-72EE55AE-BE21-47DA-85DE-A37D36CDAC07Q36746567-301210A8-BEA9-4B10-881B-E3485EB37936Q36763112-663BD711-4347-49FC-9950-BDD487F7E1D2Q37236103-E91B5A26-5917-4F52-A465-0E9054A47CABQ37426880-8CE49753-8AA7-4938-BF68-D37779CE7944Q37435222-E1B166F6-D06F-4309-BBBD-7F85DBBFEE1FQ37487137-1ABB1678-E297-4148-9FCB-5ED71656056FQ38095515-34012540-D8FF-4A2C-84A4-523591FCFD75Q38171376-BA4A55B1-349D-47AB-A894-72B4CF74F6F1Q38562599-B34F3BD4-22EF-4BB2-B964-379A4D2D15EDQ39104091-339AD777-A6B2-412E-BFBC-AD880C236DFEQ39233604-B19FBAEB-CAA1-4F5E-8F29-8376F81F1493Q39456396-B1515274-B273-4755-95D9-C95757BE54C0Q41660750-9076E987-CE49-4252-9364-E3F36F43CF77Q41766834-2F61D8A4-D765-42D6-BB65-C6AA485E4024Q41850012-F38CED3D-0EA8-4A29-859F-F6F96C812F3EQ47118717-A96A73FA-A0E9-4E8A-96CA-CCD5080BBD05Q48147806-7F25CA4F-67CE-45A2-B3FD-EF50D2BC8CE5Q48273386-68E6F1F7-2E68-4FA8-8D77-56F9F6EE61C7Q51717661-EC1F5AA4-484E-4DAF-9027-B8271A2F32DCQ55071201-A0C6ECD2-E226-4FB9-AAD6-49B6908C19DDQ55262619-63A39466-2C25-45CF-AD1A-7016CC31D50EQ56561019-F706C0B3-F897-4AA4-AA1B-6343407661CA
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Imaging key biomarkers of tumor angiogenesis
@ast
Imaging key biomarkers of tumor angiogenesis
@en
type
label
Imaging key biomarkers of tumor angiogenesis
@ast
Imaging key biomarkers of tumor angiogenesis
@en
prefLabel
Imaging key biomarkers of tumor angiogenesis
@ast
Imaging key biomarkers of tumor angiogenesis
@en
P2860
P356
P1433
P1476
Imaging key biomarkers of tumor angiogenesis
@en
P2093
Joseph M Backer
Marina V Backer
P2860
P304
P356
10.7150/THNO.3623
P577
2012-05-17T00:00:00Z